Results 71 to 80 of about 3,078,126 (290)

Peripheral intravenous therapy management

, 1999
Many nurses are involved in the management of peripheral intravenous therapy. Using scenarios of common presenting problems and evidence-based interventions, this article describes rationales for best practice.
Workman, B.
core   +4 more sources

Endothelial Cell Proteins as Biomarkers in Susac Syndrome

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Susac syndrome (SS) is a rare CD8+ T cell–mediated microangiopathy affecting the brain, retina, and auditory labyrinth. Endothelial injury is thought to be a central mechanism; however, no circulating disease biomarkers are known. We performed targeted proteomic profiling to identify circulating endothelial‐associated proteins as ...
Rohit Benjamin, Yue Andy Qi, Ying Hao, Catherine DeMarino, Samuel Darko, Irene Cortese, Daniel S. Reich, María I. Gaitán, Steven Jacobson, Bridgett J. Billioux, Bryan Smith, Avindra Nath   +11 more
wiley   +1 more source

Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) [PDF]

, 2008
<p><b>Background and Purpose:</b> The Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) unadjusted results demonstrated that intravenous alteplase is well tolerated and that the effects were comparable with ...
Wahlgren, N., Dávalos A, Hennerici MG, Kaste, M., N. Eriksson, Toni, Danilo, Bluhmki, Erich, N. Wahlgren, Hacke, Werner, Köhrmann, Martin, M. Kaste, Eriksson, Niclas, Aichner F, Ahmed N, Hacke W, Eriksson, N., Koehrmann, M., Bluhmki E, Grond M, F. Aichner, V. Larrue, G. A. Ford, D. Toni, Kaste M, Larrue, Vincent, Erila, T., Larrue, V., Eriksson, Niclas,, Aichner, F., M. G. Hennerici, Wahlgren, Nils, Davalos, A., Ford, Gary A, Grond, M., Toni, D., K. R. Lees, null null, Hennerici, Michael G, T. Erila, Roine, Risto O, Hacke, W., Koehrmann, Martin, Davalos, Antoni, Eriksson N, W. Hacke, Larrue V, Erilä, Terttu, A. Davalos, Aichner, Franz, Bluhmki, E., Wahlgren N, Roine RO, Machnig, T., M. Grond, Vanhooren, Geert, Ford, G.A., Roine, R.O., Hennerici, Michael G., Lees, K.R., Roine, Risto O., E. Bluhmki, Hennerici, M.G., Lees KR, Grond, Martin, Kaste, Markku, Köhrmann M, Peeters, André, Ahmed, Niaz, Machnig, Thomas, Machnig T, Vanhooren G., Erilä T, M. Kohrmann, Ahmed, N., R. O. Roine, Lees, Kennedy R., Ford GA, G. Vanhooren, Vanhooren, G., Lees, Kennedy R, Ford, Gary A., T. Machnig, N. Ahmed, Grond, M, Wahlgren, N,, Aichner, F, Erila, T, Hacke, W, Davalos, A, Eriksson, N, Ford, GA, Ahmed, N,, Bluhmki, E   +92 more
core   +1 more source

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui, Jiayang Zhan, Wei Li, Tao Jin, Dan He, Daishi Tian, Zhijun Li, Jing Lin, Yue Li, Hongyu Zhou, Bitao Bu   +10 more
wiley   +1 more source

Other title: What does the Occupational Therapy, Physical Therapy, and Athletic Trainers Board say about telehealth?

, 2020
"Created: 3/16/2020..."--Document properties ...
Ohio Occupational Therapy, Physical Therapy, and Athletic Trainers Board
core  

The Comprehensive Live Cell‐Based Cytotoxicity Assay for Monitoring Disease Activity and Guiding Rescue Therapy in Acute Attacks of NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu, Jie Ding, Yupeng Du, Guibao Luo, Jinming Li, Rui Liu, Xiaoyi Xu, Xiao Li, Minshu Li, Wei Jiang, Chunsheng Yang   +10 more
wiley   +1 more source

INTRAVENOUS THERAPY [PDF]

BMJ, 1927
  +5 more sources

Diffuse MRI Edema Predicts Relapse in Cerebral Amyloid Angiopathy–Related Inflammation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To identify MRI predictors of relapse and quantify relapse and mortality risk in cerebral amyloid angiopathy–related inflammation (CAA‐RI). A secondary objective was to assess the association between mycophenolate mofetil use and relapse risk. Methods We performed a retrospective cohort study of 36 patients with CAA‐RI treated at the
G. Abbas Kharal, Gowtham Yerneni, Kim J. Griffin, Nicolas Thompson, Ken Uchino, Irene Katzan, Dolora Wisco, Abeer Farrag, Jayashree Sundarajan, Andrew Russman, M. Shazam Hussain   +10 more
wiley   +1 more source

The mediating effect of emotion dysregulation on the relationship between childhood maltreatment and suicidal ideation in patients with depression

Frontiers in Psychology
BackgroundChildhood maltreatment is a well-established risk factor for suicidal ideation in patients with depression. However, the psychological mechanisms linking early adversity to current suicide risk remain incompletely understood.
Lina Chen, Lina Chen, Yuling Feng, Yong Wang, Nana Xiong, Lixia Li, Xia Li   +6 more
doaj   +1 more source

Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐NMDA Receptor Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley   +1 more source